Inactive Instrument

FUREN Group Pharmaceutical Co.,Ltd. Stock price

Equities

600781

CNE000000NM4

Pharmaceuticals

Dynamic Chart
FUREN Group Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
FUREN Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
FUREN Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
FUREN Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
FUREN Group Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
FUREN Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Furen Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Furen Group Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Furen Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Furen Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020 CI
Furen Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020 CI
Furen Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019 CI
FUREN Group Pharmaceutical Co., Ltd. Appoints Zhu Wenliang as General Manager CI
Furen Group Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020 CI
FUREN Group Pharmaceutical Co., Ltd. Elects Huang Dianying as Independent Director CI
More news
FUREN Group Pharmaceutical Co., Ltd., formerly Furen Pharmaceutical Group Industry Co., Ltd., is a China-based company principally engaged in the manufacturing, wholesale and retail of pharmaceuticals. The Company's principal business is the manufacture of proprietary Chinese medicines, including capsules, tablets, granules, gels, injections, suspensions, drops, syrups and others. The Company mainly distributes its products in the domestic market.
More about the company
  1. Stock
  2. Equities
  3. Stock FUREN Group Pharmaceutical Co.,Ltd. - Shanghai S.E.